AmeriWater, LLC

AmeriWater, LLC specializes in advanced water purification solutions for healthcare, industrial, and dialysis sectors, ensuring high-quality and safe water for various applications. Founded in 1995 in Dayton, US, AmeriWater provides tailored water purification systems. The company underwent significant changes when it was acquired by Edgewater Capital Partners from Empire Investment Holdings in July 2022. The acquisition aims to support AmeriWater's growth and expand its product portfolio.

The current CEO includes Dennis Mahoney, Diane Dolan, and Greg Reny. AmeriWater specializes in providing advanced water purification systems and solutions tailored for the healthcare, industrial, and dialysis sectors. Their core offerings include deionizers, reverse osmosis systems, high-efficiency sand filters, and various filtration systems, aimed at ensuring the quality and safety of water used in medical and industrial applications. Notably, their TIR34/ST108 portfolio addresses the specific needs of sterile processing departments and dialysis facilities, enabling them to maintain rigorous infection control and operational efficiency.

AmeriWater’s products are designed with flexibility and user-friendliness in mind, catering to a diverse client base that includes hospitals, dialysis centers, and industrial operations across the United States and select international markets, where they serve customers looking for reliable and certified water treatment solutions. AmeriWater generates revenue through direct sales of its water purification systems and associated services, primarily targeting B2B markets such as healthcare facilities and industrial clients. The transaction structure typically involves one-time sales combined with potential service agreements for ongoing maintenance and support, allowing for sustained client relationships. The company’s flagship products, such as their commercial deionizers and reverse osmosis systems, are priced to reflect their quality and reliability, addressing the needs of specific sectors such as dialysis and sterile processing.

Additionally, AmeriWater's recent GSA Multi-Award Schedule indicates a robust partnership with federal entities, diversifying their revenue streams through government contracts for water purification solutions. AmeriWater aims to enhance its product offerings and expand its market presence following its acquisition by Edgewater Capital Partners in July 2022. The company plans to introduce new products to its portfolio, focusing on advanced water purification technologies tailored for emerging healthcare needs. Moreover, AmeriWater is targeting expansion into additional markets and geographic regions, though specific areas and timelines have yet to be disclosed.

The recent acquisition will support these initiatives by providing necessary resources and strategic direction.